Review



primary antibodies against presynaptic terminal markers sv2  (Developmental Studies Hybridoma Bank)


Bioz Verified Symbol Developmental Studies Hybridoma Bank is a verified supplier
Bioz Manufacturer Symbol Developmental Studies Hybridoma Bank manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Developmental Studies Hybridoma Bank primary antibodies against presynaptic terminal markers sv2
    Primary Antibodies Against Presynaptic Terminal Markers Sv2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 97/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+presynaptic+terminal+markers+sv2/anti-Synaptic+vesicle+glycoprotein+2A/pm41752064-222-51-60
    Average 97 stars, based on 108 article reviews
    primary antibodies against presynaptic terminal markers sv2 - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Spatiotemporal Remodeling of Presynaptic Terminals in Human Neuromuscular Junctions.
    Article Snippet: .. Paraffin-embedded tissue sections were deparaffinized and subjected to heat-induced antigen retrieval in citrate buffer (pH 6.0) for 30 min. After cooling in water, slides were rinsed twice in PBS containing 0.1% Tween-20 (9127.1, Carl Roth) and subsequently blocked in UltraCruz Blocking Reagent (Santa Cruz Biotechnology, Dallas, TX, USA) for 60 min. Primary antibodies against presynaptic terminal markers SV2 (1:100; AB2315387; DSHB) and 2H3 (1:100; AB531793; DSHB) were diluted in UltraCruz Blocking Reagent (Santa Cruz Biotechnology) and applied overnight at 4 ◦C. .. Next day, primary antibodies against macrophage markers CD80 (1:1000; ab134120, Abcam, Cambridge, UK) and CD206 (1:100; PA5-101657, Thermo Fisher Scientific) were diluted in UltraCruz Blocking Reagent (Santa Cruz Biotechnology), added to the reaction, and incubated at 4 ◦C for another 24 hrs.

    Article Title: Spatiotemporal Remodeling of Presynaptic Terminals in Human Neuromuscular Junctions
    Article Snippet: .. Paraffin-embedded tissue sections were deparaffinized and subjected to heat-induced antigen retrieval in citrate buffer (pH 6.0) for 30 min. After cooling in water, slides were rinsed twice in PBS containing 0.1% Tween-20 (9127.1, Carl Roth) and subsequently blocked in UltraCruz Blocking Reagent (Santa Cruz Biotechnology, Dallas, TX, USA) for 60 min. Primary antibodies against presynaptic terminal markers SV2 (1:100; AB2315387; DSHB) and 2H3 (1:100; AB531793 ; DSHB) were diluted in UltraCruz Blocking Reagent (Santa Cruz Biotechnology) and applied overnight at 4 °C. .. Next day, primary antibodies against macrophage markers CD80 (1:1000; ab134120, Abcam, Cambridge, UK) and CD206 (1:100; PA5-101657, Thermo Fisher Scientific) were diluted in UltraCruz Blocking Reagent (Santa Cruz Biotechnology), added to the reaction, and incubated at 4 °C for another 24 hrs.



    Similar Products

    97
    Developmental Studies Hybridoma Bank primary antibodies against presynaptic terminal markers sv2
    Primary Antibodies Against Presynaptic Terminal Markers Sv2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+presynaptic+terminal+markers+sv2/anti-Synaptic+vesicle+glycoprotein+2A/pm41752064-222-51-60
    Average 97 stars, based on 1 article reviews
    primary antibodies against presynaptic terminal markers sv2 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    Image Search Results